Abstract
Objective StartReact elicits faster, larger, and more appropriate muscle activation in stroke survivors but has been only cursorily studied to date during multi-jointed reaching. Our objective was to evaluate StartReact on unrestricted, two-dimensional point-to-point reaching tasks post-stroke.
Method Data from 23 individuals with stroke was collected during point-to-point reaching. Voluntary and StartReact trials were compared between mild, severe/moderate, and the unimpaired arm.
Results StartReact showed an increase in probability of muscle activity, larger muscle activity amplitude and faster muscle activity onset. Despite changes in muscle activity, metrics of movement (distance, final error, linear deviation) were largely the same between StartReact and Voluntary trials except in severe/moderate stroke who had larger reaching distances during StartReact.
Conclusion While StartReact impacted many metrics of muscle activity, the most profound effect was on probability of muscle activity increasing 34% compared to Voluntary which allowed severe/moderate subjects to increase reaching distance but did not translate to decrease in final error suggesting that the additional movement was not always directed towards the appropriate target.
Significance These results indicate that SR has the capacity to activate paralyzed muscle in severe/moderate patients, but future studies are needed to explore the possible use of SR in the rehabilitation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Institutes of Health (R00 HD073240).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
all data is available in human mobility lab.
